N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide

C16H24N4O3 — CID 97461365

IUPACN-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide
SMILESCn1ccnc1C(=O)N[C@H]1CN([C@H]2CCOC2)[C@@H]2CCCO[C@H]12
InChIInChI=1S/C16H24N4O3/c1-19-6-5-17-15(19)16(21)18-12-9-20(11-4-8-22-10-11)13-3-2-7-23-14(12)13/h5-6,11-14H,2-4,7-10H2,1H3,(H,18,21)/t11-,12-,13+,14+/m0/s1
InChIKeyUHFGZSZOUFWVAU-IGQOVBAYSA-N
MW320.39 g/mol
LogP0.17
Rot. Bonds3

About N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide

N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide (PubChem CID 97461365) has the molecular formula C16H24N4O3 and a molecular weight of 320.39 g/mol. Its IUPAC name is N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide.

Molecular Properties

Compound NameN-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide
PubChem CID97461365
Molecular FormulaC16H24N4O3
Molecular Weight320.39 g/mol
Exact Mass320.18
IUPAC NameN-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide
SMILESCn1ccnc1C(=O)N[C@H]1CN([C@H]2CCOC2)[C@@H]2CCCO[C@H]12
InChIInChI=1S/C16H24N4O3/c1-19-6-5-17-15(19)16(21)18-12-9-20(11-4-8-22-10-11)13-3-2-7-23-14(12)13/h5-6,11-14H,2-4,7-10H2,1H3,(H,18,21)/t11-,12-,13+,14+/m0/s1
InChIKeyUHFGZSZOUFWVAU-IGQOVBAYSA-N
XLogP0.17
TPSA68.62 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms23
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500320.39
LogP ≤ 50.17
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide?
The IUPAC name of N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide (CID 97461365) is N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide.
What is the SMILES notation for N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide?
The canonical SMILES for N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide is Cn1ccnc1C(=O)N[C@H]1CN([C@H]2CCOC2)[C@@H]2CCCO[C@H]12.
What is the InChIKey of N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide?
The InChIKey is UHFGZSZOUFWVAU-IGQOVBAYSA-N. The full InChI is InChI=1S/C16H24N4O3/c1-19-6-5-17-15(19)16(21)18-12-9-20(11-4-8-22-10-11)13-3-2-7-23-14(12)13/h5-6,11-14H,2-4,7-10H2,1H3,(H,18,21)/t11-,12-,13+,14+/m0/s1.
What are the key properties of N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide?
N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide has a molecular weight of 320.39 g/mol, XLogP of 0.17, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,3aR,7aR)-1-[(3S)-oxolan-3-yl]-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrol-3-yl]-1-methylimidazole-2-carboxamide is sourced from PubChem (CID 97461365), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).